Investing Profile
Michael Rome
VCInvestor
Managing Director & Co-Head of Therapeutics Investing at Foresite Capital
foresitecapital.com/people/mi...Los Angeles, California
Your Intro Paths to Michael Rome
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
UCLA Network
19 CONNECTIONS
California Institute of Technology Network
14 CONNECTIONS
Find Michael Rome on
cbCurrent Investing Position
Foresite Capital Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
7
Current Fund Size
$668M
Michael Rome is on these Sector & Stage Rankings
Michael Rome's Investments On Record (6)
Company | StageDateRound Size | Total Raised |
---|---|---|
Remix Therapeutics | Series BMay 2022$70M Series ADec 2020$65M | $140M |
XinThera | Series BAug 2021$50M | $50M |
Alumis | Series AMay 2021$70M | $70M |
Theseus Pharmaceuticals | Series BApr 2021$100M | $100M |
Nurix Therapeutics | Private Equity RoundMar 2020$120M | $150M |
Kinnate Biopharma | Series BDec 2019$75M | $170M |
Michael Rome's Experience
Senior Analyst Foresite Capital ManagementPresent
Analyst DAFNA Capital Management, LLCPresent
Scientist and Senior Scientist Vault PharmaPresent
Graduate Researcher in Biochemistry CaltechPresent
Research Associate in Microbiology UCLAPresent
Lab Assistant and Researcher UCLAPresent
Physical Sciences Tutor Los Angeles Valley CollegePresent
Office Assistant Impact Program for Prostate Cancer TreatmentPresent
Michael Rome's Education
California Institute of Technology Doctor of Philosophy (Ph.D.) Biochemistry, Biophysics and Molecular Biology
UCLA BS Molecular, Cellular and Developmental Biology
Investors who invest with Michael Rome